- 7912
- 467
- 10
- 6
- 0
- Help Ukraine
About the solution
This is something to which few Type 1 diabetics in Britain have access – the monitors cost around £4,000 a year to buy and maintain and are too expensive for the NHS.
“I now have more information about my condition, so I better understand what I am doing. I feel more in control – and that is a massive improvement,” he says.
Tim decided to create his own glucose monitor because he was tired of waiting for the pharmaceutical and medical device companies to come up with new, affordable ways to improve the lives of diabetic patients, he has taken matters into his own hands. So he bought an old continuous glucose monitor (CGM) from the internet and used his skills as an IT specialist to re-engineer it so that it communicates, via a self-built Tic Tac box receiver he keeps in his pocket, with his mobile phone and his smartwatch – something even the full-price version will not do. The total annual cost is about £1,000. With a couple of taps on the screen, his blood glucose level is displayed as a graph.
“Diabetes is all about managing your data – on medication, food and blood glucose,” says Omer. “Current tools are not up to the job and I struggle to keep up. We need help.” His next goal is to obtain an automatic calculation of the amount of insulin he needs, based on his glucose level and other factors, as a step towards creating an artificial pancreas. He has teamed up with the charity Great Britain Diabetes Online Community to bring his findings to a wider audience.
“My aim is to publish my work, and others’, so as many people as possible can benefit. If you try to commercialise [your own products], you run up against all sorts of regulatory barriers,” he says.
Adapted from: http://bit.ly/1P1K9Lb
More info: http://www.hypodiabetic.co.uk/
这些解决方案不应包括使用药物,化学品或生物制品(包括食品);创伤性设备;冒犯性的,商业或内在危险的内容。该解决方案未经医学验证。请谨慎进行!如果您有任何疑问,请咨询健康专家。
DISCLAIMER: This story was written by someone who is not the author of the solution, therefore please be advised that, although it was written with the utmost respect for the innovation and the innovator, there can be some incorrect statements. If you find any errors please contact the patient Innovation team via info@patient-innovation.com
-
-
526
-
0
-
13667
Nightscout – an open source, do-it-yourself continuous glucose monitor in the Cloud
Type 1 diabetes mellitus
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Fulminant type 1 diabetes mellitus
Cystic fibrosis related diabetes
Gestational diabetes
Insulin-requiring type 2 diabetes mellitus
Latent autoimmune diabetes in adults
Diabetes with hyperosmolarity
Diabetes complicating pregnancy
Insulin resistant diabetes
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Glucose metabolism disorders (incl diabetes mellitus)
Nephrogenic diabetes insipidus
Acquired lipoatrophic diabetes
Congenital central diabetes insipidus
Hyperglycaemia
Carbohydrate metabolism disorder
Inborn errors of carbohydrate metabolism (excl glucose)
Pancreas
Mobile app
Software
Insulin injector
Insulin pen
Insulin injection
Diabetes mellitus management
CAREGIVING
(SELF)-CARE: EATING: Eating independently.
(SELF)-CARE: DRINKING: Drinking independently.
diabetes type 1
diabetes type 2
Gestational Diabetes
App (Including when connected with wearable)
Promoting self-management
Managing diabetes
To implement a diagnostic tool
Preventing (Vaccination, Protection, Falls, Research/Mapping)
Caregiving Support
Endocrinology
General and Family Medicine
Internal Medicine
-
-
-
511
-
0
-
11493
I-Port™ – Medication delivery device
Type 1 diabetes mellitus
Diabetes complicating pregnancy
Diabetes mellitus
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Latent autoimmune diabetes in adults
Insulin resistant diabetes
Insulin-requiring type 2 diabetes mellitus
Pancreatogenous diabetes
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Gestational diabetes
Glucose metabolism disorders (incl diabetes mellitus)
Crohn's disease
Rheumatoid arthritis
Hypopituitarism
Dwarfism
Autoimmune disorders
Coagulopathy
Pancreas
Pituitary gland
Auto-injector
Insulin injector
Insulin pen
Insulin injection
Skin and subcutaneous tissue therapeutic procedures
Anticoagulant therapy
CAREGIVING
(SELF)-CARE: EATING: Eating independently.
diabetes type 1
Treatment/Surgical device
Pharma
Enhancing health literacy
Managing diabetes
Manage Medication
Endocrinology
-
-
-
434
-
12
-
11061
Diabetic invents app to manage diabetes
Diabetes mellitus (incl subtypes)
Diabetes mellitus inadequate control
Acquired lipoatrophic diabetes
Diabetes mellitus
Diabetes with hyperosmolarity
Congenital central diabetes insipidus
Diabetes complicating pregnancy
Diabetes mellitus malnutrition-related
Diabetes insipidus
Cystic fibrosis related diabetes
Insulin-requiring type 2 diabetes mellitus
Type 1 diabetes mellitus
Congenital nephrogenic diabetes insipidus
Insulin resistant diabetes
Fulminant type 1 diabetes mellitus
Gestational diabetes
Latent autoimmune diabetes in adults
Type 2 diabetes mellitus
Type 3 diabetes mellitus
Pancreatogenous diabetes
Nephrogenic diabetes insipidus
Mobile app
COMMUNICATION: Communicating, whether by speaking, listening, or other means
(SELF)-CARE: EATING: Eating independently.
(SELF)-CARE: DRINKING: Drinking independently.
diabetes type 1
diabetes type 2
App (Including when connected with wearable)
Depression or anxiety
Dry skin
Excessive thirst or hunger
Fatigue or lethargy
Increased urination
Muscle weakness
Weight gain or loss
Managing diabetes
To improve Treatment/Therapy
Raise awareness
Endocrinology
General and Family Medicine
-